Non-vitamin K antagonist oral anticoagulant use at doses inappropriately lower than recommended in outpatient older adults: a real-life data.

Erdogan T., Erdogan O., Ozturk S., Oren M. M., Karan M. A., BAHAT-ÖZTÜRK G.

European geriatric medicine, vol.12, no.4, pp.809-816, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.1007/s41999-021-00452-0
  • Journal Name: European geriatric medicine
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.809-816
  • Keywords: Atrial fibrillation, Inappropriate drug use, Low dose, Non-vitamin K antagonist oral anticoagulants
  • Istanbul University Affiliated: Yes

Abstract

Background/Purpose There has been a rapid increase in the use of non-vitamin K-antagonist oral anticoagulants (NOAC). Current guidelines recommend dose adjustments be made in accordance with certain criteria for each NOAC. This study is aimed at determining whether or not NOAC were prescribed for non-valvular atrial fibrillation (AF) in guideline-recommended doses in community-dwelling older adults.